Hugh Cole Net Worth & Insider Trades
Hugh Cole - Chief Operating Officer, Jounce Therapeutics, Inc
What is Hugh Cole's Net Worth?
The current estimated net worth of Jounce Therapeutics, Inc's Chief Operating Officer, Hugh Cole, is estimated to be about $836.26K . Hugh Cole owns about 110,082 units of Jounce Therapeutics, Inc common stock. In the last 5 years at Jounce Therapeutics, Inc, Hugh Cole has sold an estimated value of $383.02K worth.
What is Hugh Cole's Past Insider Trading?
Hugh Cole's largest purchase order was 10,000 units , worth over $54.75K on January 25, 2021. Hugh Cole's largest sale order was 18,000 units , worth over $215.1K on January 25, 2021. In total, Hugh Cole has made about 15 transactions over 5 years of their time at Jounce Therapeutics, Inc. Hugh Cole usually trades in January and February, with the busiest year in 2020, 2021, 2018 and 2022. The most recent transaction was a sale order of 16,634 units , worth over $18.48K on January 11, 2023.
Hugh Cole
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Hugh Cole's Salary in 2020?
As Chief Operating Officer of Jounce Therapeutics, Inc, Hugh Cole has a total base salary of $420,000 . Hugh Cole received compensation valued at about $1,088,736 in 2020 after becoming Chief Operating Officer. The vast majority of their compensation came in the form of a bonus of $212,520 , stock awards of $196,500 , option awards of $250,908 , and other compensation of $8,808 .
What is Hugh Cole's' Mailing Address?
- Mailing address is C/o Ariad Pharmaceuticals, Inc 26 Landsdowne Street Cambridge MA 02139 MA
Jounce Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Richard Murray, Ph.D., | 2020 | $565,100 | $310,810 | $491,316 | $627,312 | $8,946 | $2,003,484 |
| Richard Murray, Ph.D., | 2019 | $540,800 | $295,500 | $275,044 | $348,665 | $8,796 | $1,468,805 |
| Hugh M. Cole | 2020 | $420,000 | $212,520 | $196,500 | $250,908 | $8,808 | $1,088,736 |
| Hugh M. Cole | 2019 | $401,700 | $153,700 | $97,900 | $124,115 | $5,709 | $783,124 |
| Kim C. Drapkin | 2020 | $398,400 | $175,300 | $174,885 | $223,308 | $8,688 | $980,581 |
| Kim C. Drapkin | 2019 | $381,200 | $145,800 | $97,900 | $124,115 | $8,796 | $757,811 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1640455/000164045521000078/jnce042621def14a.htm
What are Jounce Therapeutics, Inc's Past Insider Trades?
Jounce Therapeutics, Inc's most recent insider trade came on April 6, 2023 by Ca Richard Murray who sold 39,228 units worth $72.57K . In the last 6 years, insiders at Jounce Therapeutics, Inc have sold an estimated value of $52.4M and bought an estimated value of $10.81M worth of shares. Insider trading is most common in June, with the busiest year in 2021. The most active traders at the company are Kimberlee C Drapkin, President, Ca Richard Murray, Director, and Elizabeth Trehu, Chief Medical Officer .
Jounce Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||